Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

CCR4 Expression in Hodgkin Lymphoma

Lydia Visser, Myrna van West, Bea Rutgers, Sibrand Poppema, Anke Van Den Berg, PhD

Blood (2011) 118 (21): 2626.

https://doi.org/10.1182/blood.V118.21.2626.2626

Published: 2011

Journal Articles

Multiple HLA class I and II associations in classical Hodgkin lymphoma and EBV status defined subgroups

Xin Huang, Kushi Kushekhar, Ilja Nolte, Wierd Kooistra, Lydia Visser, Ilby Bouwman, Niels Kouprie, Rianne Veenstra, Gustaaf van Imhoff, Bianca Olver, Richard S. Houlston, Sibrand Poppema, Arjan Diepstra, Bouke Hepkema, Anke van den Berg

Blood (2011) 118 (19): 5211–5217.

https://doi.org/10.1182/blood-2011-04-342998

Published: 2011

Includes: Supplemental data

Journal Articles

HLA Class I and EBV Positive Classical Hodgkin Lymphoma In the Chinese Population

Huang Xin, MD, Arjan Diepstra, MD, PhD, Zifen Gao, MD, PhD, Lydia Visser, PhD, Hans Vos, Wierd Kooistra, Sibrand Poppema, MD, PhD, Bouke Hepkema, PhD, Anke Van Den Berg, PhD

Blood (2010) 116 (21): 2688.

https://doi.org/10.1182/blood.V116.21.2688.2688

Published: 2010

Journal Articles

Expression of the c-Met Oncogene Correlates with Favorable Progression Free Survival In Classical Hodgkin Lymphoma

Chuanhui Xu, Anke Van Den Berg, PhD, Wouter Plattel, drs., Nele Ruther, Huang Xin, Sr, Miao Wang, Gustaaf Van Imhoff, MD, PhD, Andreas Viardot, Peter Möller, Sibrand Poppema, MD, PhD, Lydia Visser, PhD

Blood (2010) 116 (21): 3880.

https://doi.org/10.1182/blood.V116.21.3880.3880

Published: 2010

Journal Articles

Protective and Predisposing HLA Alleles In Dutch Classical Hodgkin Lymphoma Patients

Arjan Diepstra, MD, PhD, Xin Huang, Ilja Nolte, PhD, Bouke Hepkema, PhD, Wierd Kooistra, Lydia Visser, PhD, Sibrand Poppema, MD, PhD, Anke Van Den Berg, PhD

Blood (2010) 116 (21): 749.

https://doi.org/10.1182/blood.V116.21.749.749

Published: 2010

Journal Articles

Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell–mediated B-cell cytotoxicity

Blood (2010) 115 (22): 4393–4402.

https://doi.org/10.1182/blood-2009-06-225979

Published: 2010

Journal Articles

Contribution of Deregulated miRNAs to the Phenotypic Characteristic of Hodgkin Lymphoma.

Lu Ping Tan, BSc,MSc, Bart-Jan Kroesen, PhD, Enrico Tiacci, PhD, Gerben Duns, Erwin Seinen, Ody Sibon, PhD, Klaas Kok, PhD, Sibrand Poppema, MD, PhD, Anke Van Den Berg, PhD

Blood (2009) 114 (22): 265.

https://doi.org/10.1182/blood.V114.22.265.265

Published: 2009

Journal Articles

The HGF/c-Met Signaling Pathway in Hodgkin Lymphoma.

Chuanhui Xu, Anke Van Den Berg, PhD, Arjan Diepstra, Miao Wang, Debora Jong, Hans JTWM Vos, Peter Moller, MD, Sibrand Poppema, MD, PhD, Lydia Visser

Blood (2009) 114 (22): 1551.

https://doi.org/10.1182/blood.V114.22.1551.1551

Published: 2009

Journal Articles

Expression of CD1c, CD1d and Presence of Invariant NKT Cells in Hodgkin Lymphoma.

Chuanhui Xu, Riemer de Vries, Lydia Visser, Arjan Diepstra, Stephan D Gadola, Sibrand Poppema, MD, PhD, Anke Van Den Berg, PhD

Blood (2009) 114 (22): 3659.

https://doi.org/10.1182/blood.V114.22.3659.3659

Published: 2009

Journal Articles

Extracellular ligation-dependent CD45RB enzymatic activity negatively regulates lipid raft signal transduction

Kaushal Parikh, Sibrand Poppema, Maikel P. Peppelenbosch, Lydia Visser

Blood (2009) 113 (3): 594–603.

https://doi.org/10.1182/blood-2008-04-150987

Published: 2009

Includes: Supplemental data

Journal Articles

Repression of Mir-106b Family Members Does Not Alter Cell Cycle Progression in Hodgkin Lymphoma

Johan H Gibcus, PhD, Lu Ping Tan, BSc, MSc, Rikst Nynke Schakel, BSc, Geert Harms, BSc, Peter Moeller, MD, PhD, Sibrand Poppema, MD, PhD, Bart-Jan Kroesen, PhD, Anke Van Den Berg, PhD

Blood (2008) 112 (11): 4722.

https://doi.org/10.1182/blood.V112.11.4722.4722

Published: 2008

Journal Articles

miRNA Profiling of B Cell Subsets: Specific miRNA Profile for Germinal Center B Cells with a Marked Variation Between Centroblast and Centrocytes.

Lu Ping Tan, Miao Wang, Jan-Lukas Robertus, Rikst Nynke Schakel, Johan H Gibcus, Arjan Diepstra, Geert Harms, Suat Cheng Peh, Rogier M Reijmers, Steven T Pals, Lydia Visser, Philip Kluin, Sibrand Poppema, Bart-Jan Kroesen, Anke van den Berg

Blood (2008) 112 (11): 1459.

https://doi.org/10.1182/blood.V112.11.1459.1459

Published: 2008

Journal Articles

A High Throughput Experimental Approach to Identify miRNA Target Genes in Hodgkin Lymphoma.

Lu Ping Tan, Erwin Seinen, Gerben Duns, Debora Jong, Rikst Nynke Schakel, Geert Harms, Ody Sibon, Klaas Kok, Sibrand Poppema, Bart-Jan Kroesen, Anke van den Berg

Blood (2008) 112 (11): 1461.

https://doi.org/10.1182/blood.V112.11.1461.1461

Published: 2008

Journal Articles

Proteomics analysis of Hodgkin lymphoma: identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes

Yue Ma, Lydia Visser, Han Roelofsen, Marcel de Vries, Arjan Diepstra, Gustaaf van Imhoff, Tineke van der Wal, Marjan Luinge, Gloria Alvarez-Llamas, Hans Vos, Sibrand Poppema, Roel Vonk, Anke van den Berg

Blood (2008) 111 (4): 2339–2346.

https://doi.org/10.1182/blood-2007-09-112128

Published: 2008

Includes: Supplemental data

Journal Articles

GA101, a Novel Humanized Type II CD20 Antibody with Glycoengineered Fc and Enhanced Cell Death Induction, Exhibits Superior Anti-Tumor Efficacy and Superior Tissue B Cell Depletion In Vivo.

Blood (2007) 110 (11): 2348.

https://doi.org/10.1182/blood.V110.11.2348.2348

Published: 2007

Journal Articles

CD4+CD26 - T Cell Population in Classical Hodgkin Lymphoma Displays a Distinctive Regulatory T Cell Population.

Yue Ma, Lydia Visser, PhD, Tjasso Blokzijl, Geert Harms, Cigdem Atayar, PhD, Sibrand Poppema, MD, PhD, Anke van den Berg, PhD

Blood (2007) 110 (11): 384.

https://doi.org/10.1182/blood.V110.11.384.384

Published: 2007

Journal Articles

Specific Micro-RNA Expression Profile in Hodgkin Lymphoma.

Lu Ping Tan, MSc, Geert Harms, Tjasso Blokzijl, Rikst Nynke Schakel, Johan Gibcus, MSc, Peter Möller, MD, Ralf Küppers, Rogier M. Reijmers, MSc, Steven T. Pals, MD, PhD, Sibrand Poppema, Bart-Jan Kroesen, PhD, Anke van den Berg, PhD

Blood (2007) 110 (11): 381.

https://doi.org/10.1182/blood.V110.11.381.381

Published: 2007

Journal Articles

HLA-A02 is associated with a reduced risk and HLA-A01 with an increased risk of developing EBV + Hodgkin lymphoma

Marijke Niens, Ruth F. Jarrett, Bouke Hepkema, Ilja M. Nolte, Arjan Diepstra, Mathieu Platteel, Niels Kouprie, Craig P. Delury, Alice Gallagher, Lydia Visser, Sibrand Poppema, Gerard J. te Meerman, Anke van den Berg

Blood (2007) 110 (9): 3310–3315.

https://doi.org/10.1182/blood-2007-05-086934

Published: 2007

Journal Articles

Novel 3 rd Generation Humanized Type II CD20 Antibody with Glycoengineered Fc and Modified Elbow Hinge for Enhanced ADCC and Superior Apoptosis Induction.

Blood (2006) 108 (11): 229.

https://doi.org/10.1182/blood.V108.11.229.229

Published: 2006

Journal Articles

Regulation of pri-miRNA BIC Transcription and Processing in Burkitt Lymphoma.

Anke van den Berg, PhD, Joost Kluiver, PhD, Debora de Jong, Tjasso Blokzijl, Geert Harms, Susan Jacobs, Sibrand Poppema, MD PhD, Bart-Jan Kroesen, PhD

Blood (2006) 108 (11): 2380.

https://doi.org/10.1182/blood.V108.11.2380.2380

Published: 2006

NARROW

CCR4 Expression in Hodgkin Lymphoma

Multiple HLA class I and II associations in classical Hodgkin lymphoma and EBV status defined subgroups

HLA Class I and EBV Positive Classical Hodgkin Lymphoma In the Chinese Population

Expression of the c-Met Oncogene Correlates with Favorable Progression Free Survival In Classical Hodgkin Lymphoma

Protective and Predisposing HLA Alleles In Dutch Classical Hodgkin Lymphoma Patients

Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell–mediated B-cell cytotoxicity

Contribution of Deregulated miRNAs to the Phenotypic Characteristic of Hodgkin Lymphoma.

The HGF/c-Met Signaling Pathway in Hodgkin Lymphoma.

Expression of CD1c, CD1d and Presence of Invariant NKT Cells in Hodgkin Lymphoma.

Extracellular ligation-dependent CD45RB enzymatic activity negatively regulates lipid raft signal transduction

Repression of Mir-106b Family Members Does Not Alter Cell Cycle Progression in Hodgkin Lymphoma

miRNA Profiling of B Cell Subsets: Specific miRNA Profile for Germinal Center B Cells with a Marked Variation Between Centroblast and Centrocytes.

A High Throughput Experimental Approach to Identify miRNA Target Genes in Hodgkin Lymphoma.

Proteomics analysis of Hodgkin lymphoma: identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes

GA101, a Novel Humanized Type II CD20 Antibody with Glycoengineered Fc and Enhanced Cell Death Induction, Exhibits Superior Anti-Tumor Efficacy and Superior Tissue B Cell Depletion In Vivo.

CD4+CD26 - T Cell Population in Classical Hodgkin Lymphoma Displays a Distinctive Regulatory T Cell Population.

Specific Micro-RNA Expression Profile in Hodgkin Lymphoma.

HLA-A02 is associated with a reduced risk and HLA-A01 with an increased risk of developing EBV + Hodgkin lymphoma

Novel 3 rd Generation Humanized Type II CD20 Antibody with Glycoengineered Fc and Modified Elbow Hinge for Enhanced ADCC and Superior Apoptosis Induction.

Regulation of pri-miRNA BIC Transcription and Processing in Burkitt Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only